S002 Chronic Pruritus: Bedside to Bench Perspectives
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Itch impacts quality of life to the same extent as chronic pain. Advances in understanding itch has resulted in a revolution in therapies. This session is geared toward the practicing physician. It addresses itch from children with atopic dermatitis, to the elder population, and those who itch from the adverse impact of immunomodulators used to treat melanoma. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Formulate practical management tips for itch
Utilize new drugs that target itch pathophysiology
Evaluate and manage acute and chronic itches
SCHEDULE
2:00 PM
Introduction to itch
Ethan A. Lerner, MD, PhD, FAAD
2:05 PM
Physiology of itch
Brian S Kim, MD, FAAD
2:30 PM
Measuring itch
Emily Cole, MD, MPH, FAAD
3:00 PM
Urticaria: We might understand it!
Martin Metz, MD
3:30 PM
The itchy microbiome
Tammy Gonzalez, MD, PhD
3:50 PM
Itch and aging
Daniel Charles Butler, MD, FAAD
4:10 PM
Itch and cancer therapeutics
Yevgeniy Semenov, MD, MS, FAAD
4:30 PM
Therapeutic landscape
Gil Yosipovitch, MD
4:45 PM
Q&A
SPEAKERS
Daniel Charles Butler, MD, FAAD
Emily Cole, MD, MPH, FAAD
Tammy Gonzalez, MD, PhD
Brian S Kim, MD, FAAD
Ethan A. Lerner, MD, PhD, FAAD
Martin Metz, MD
Yevgeniy Semenov, MD, MS, FAAD
Gil Yosipovitch, MD
HANDOUTS
SPEAKER DISCLOSURES
Daniel Charles Butler, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Galderma – Advisory Board(Fees); Leo Pharma Inc – Advisory Board(Fees); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Speaker(Honoraria);
Emily Cole, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Tammy Gonzalez, MD, PhD
No financial relationships exist with ineligible companies.
Brian S Kim, MD, FAAD
23andMe – Consultant (1099 relationship)(Fees); AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Amagma Therapeutics – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); AstraZeneca – Consultant (1099 relationship)(Fees); Bellus Health – Advisory Board(Honoraria); Blueprint Medicines – Board of Directors(Honoraria); BMS – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Clexio – Consultant (1099 relationship)(Fees); Daewoong Pharmaceuticals – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Genentech, Inc. – Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees); Granular Therapeutics – Consultant(Fees); Guidepoint Global, LLC – Consultant(Fees); Incyte Corporation – Consultant(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Klirna – Founder(Stock); Klirna Biotech, Inc. – Founder(Stock); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Micreos – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Nuogen Pharma – Founder(Stock); OM Pharma – Consultant(Fees); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Sanofi – Consultant(Fees); Sanofi Genzyme – Consultant(Fees); Sanofi/Regeneron – Advisory Board(Honoraria); Septerna – Consultant (1099 relationship)(Fees); Shaperon – Consultant(Fees); Teva Pharmaceuticals USA – Advisory Board(Fees); Trevi Therapeutics – Consultant(Fees); VeraDermics Inc. – Investigator(Fees);
Ethan A. Lerner, MD, PhD, FAAD
Eli Lilly – Speaker/Faculty Education(Honoraria); Escient – Advisory Board(Fees); Pfizer – Consultant (1099 relationship)(Fees);
Martin Metz, MD
AbbVie – Speaker(Honoraria); Alk-Abelló – Speaker/Faculty Education(Honoraria); Almirall – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); argenx – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); AstraZeneca – Advisory Board(Honoraria); Astria Therapeutics – Advisory Board(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Celldex – Advisory Board(Honoraria); Celltrion – Speaker(Honoraria); Deep Apple Therapeutics – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Advisory Board(Honoraria); Evommune, Inc. – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); Granular Therapeutics – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Jasper Therapeutics – Advisory Board(Honoraria); Johnson & Johnson Pharmaceutical Research & Development – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); RAPT Therapeutics – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); Santa Ana Bio – Advisory Board(Honoraria); Septerna – Advisory Board(Honoraria);
Yevgeniy Semenov, MD, MS, FAAD
Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Journal of the American Academy of Dermatology – Other(Salary); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Gil Yosipovitch, MD
AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);